Current methods for detecting and assessing HIV-1 antibody resistance
Antiretroviral therapy is the standard treatment for HIV, but it requires daily use and can cause side effects. Despite being available for decades, there are still 1.5 million new infections and 700,000 deaths each year, highlighting the need for better therapies. Broadly neutralizing antibodies (b...
Saved in:
Main Authors: | Stanley Odidika, Martin Pirkl, Thomas Lengauer, Philipp Schommers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1443377/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01) -
Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O
by: Yimei Cao, et al.
Published: (2025-02-01) -
Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01) -
Standardization, validation, and comparative evaluation of a convenient surrogate recombinant vesicular stomatitis virus plaque reduction test for quantification of Hantaan orthohantavirus (HTNV) neutralizing antibodies
by: Jing Wei, et al.
Published: (2025-02-01) -
Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial
by: Chaoying Hu, et al.
Published: (2024-12-01)